Medical Therapy. Efficacy or Lack of Efficacy

Outcomes of neonatal chylous effusions: A 20-year west-Australian tertiary center experience

A. Anvekar, G. Athalye-Jape, H. Panchal, S. Rao, R. KohanFiona Stanley Hospital. King Edward Memorial Hospital. Perth Children Hospital.Australia LymphologyLymphology 2021; 54: 204-213DOI Not Available AbstractNeonatal chylous effusions are rare entity with limited evidence-based management. We conducted a retrospective review of neonates admitted to King Edward Memorial and Princess Margaret/Perth Children’s Hospital over 20 years […]

Outcomes of neonatal chylous effusions: A 20-year west-Australian tertiary center experience Read More »

Use of Propranolol in the Treatment of Chylous Effusions in Infants

Kaitlin Mitchell, Angela Weiner, Patricia Ramsay, Mitali SahniPediatrix Medical Group of Nevada and University of Nevada.United States PediatricsPediatrics 2021; 148: DOI: 10.1542/peds.2020-049699 AbstractChylothorax and chyloperitoneum are rare in infants and challenging to definitively diagnose by using current criteria extrapolated from the adult population. They can be of primary or secondary etiologies, including congenital lymphatic malformations and

Use of Propranolol in the Treatment of Chylous Effusions in Infants Read More »

Dietary treatment of congenital chylothorax with skimmed breast milk

Michaela Höck, Alexander Höller, Marlene Hammerl, Karina Wechselberger, Jakob Krösslhuber, Ursula Kiechl-Kohlendorfer, Sabine Scholl-Bürgi, Daniela KarallMedical University of Innsbruck. Austria Italian Journal of PediatricsItal J Pediatr 2021; 47: DOI: 10.1186/s13052-021-01125-1 AbstractBackground: Congenital chylothorax (CC) is a rare but potentially life-threatening condition in newborns. It is defined as an accumulation of chyle in the pleural cavity. The few

Dietary treatment of congenital chylothorax with skimmed breast milk Read More »

The use of high dose octreotide in management of neonatal chylothorax: Review

M. A. AlhasoonUnaizah College of Medicine and Medical Sciences and Qassim University.Saudi Arabia Journal of Neonatal and Perinatal MedicineJ Neonatal Perinatal Med 2021; 14: 457-461DOI: 10.3233/NPM-200644 AbstractBackground: Being a rare condition, the incidence of chylothorax among neonates is low, but the mortality rate is high. In a dire effort to reduce the risk of death, octreotide treatment

The use of high dose octreotide in management of neonatal chylothorax: Review Read More »

Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders

Emmanuel Mas, Osvaldo Borrelli, Ilse Broekaert, J. Martin de-Carpi, Jernej Dolinsek, Erasmo Miele, Corina Pienar, C. Ribes Koninckx, Ruth-Anne Thomassen, Mike Thomson, Christo Tzivinikos, Marc A. BenningaHôpital des Enfants and Université de Toulouse. Great Ormond Street Hospital. University Hospital Cologne and University of Cologne. Hospital Sant Joan de Déu. University Medical Centre Maribor. University of

Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders Read More »

Medical Interventions for Chylothorax and their Impacts on Need for Surgical Intervention and Admission Characteristics: A Multicenter, Retrospective Insight

Rohit S. Loomba, Joshua Wong, Megan Davis, Sarah Kane, Brian Heenan, Juan S. Farias, Enrique G. Villarreal, Saul FloresChicago Medical School and Advocate Children’s Hospital. Escuela de Medicina y Ciencias de la Salud. Texas Children’s Hospital.United States and Mexico Pediatric CardiologyPediatr Cardiol 2021; 42: 543-553DOI: 10.1007/s00246-020-02512-x AbstractThe incidence of chylothorax is reported from 1-9% in pediatric

Medical Interventions for Chylothorax and their Impacts on Need for Surgical Intervention and Admission Characteristics: A Multicenter, Retrospective Insight Read More »

Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis

Ryan Callahan, Mark W. Kieran, Christopher W. Baird, Steven D. Colan, Kimberlee Gauvreau, Chistina M. Ireland, Audrey Marshall, Laureen M. Sena, Sara O. Vargas, Kathy J. JenkinsBoston Children’s Hospital and Harvard Medical School. Floating Hospital for Children at Tufts Medical Center. UMass Memorial Medical Center.United States Journal of PediatricsJ Pediatr 2018; 198: 29-35DOI: 10.1016/j.jpeds.2018.01.029 AbstractObjective: To evaluate

Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis Read More »

Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis

Richard W. B. van Duin, Kelly Stam, André Uitterdijk, Beatrijs Bartelds, A. H. Jan Danser, Irwin K. M. Reiss, Dirk J. Duncker, Daphne MerkusErasmus MC Rotterdam. Sophia Children’s Hospital. University Hospital, LMU Munich.Netherlands and Germany Journal of Clinical MedicineJ Clin Med 2019; 8: DOI: 10.3390/jcm8081204 AbstractPulmonary hypertension (PH) as a result of pulmonary vein stenosis (PVS)

Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis Read More »

Systemic Sirolimus to Prevent In-Stent Stenosis in Pediatric Pulmonary Vein Stenosis

Ryan Callahan, Jesse J. Esch, Grace Wang, Christina M. Ireland, Kimberlee Gauvreau, Kathy J. JenkinsBoston Children’s Hospital and Harvard Medical School.United States Pediatric CardiologyPediatr Cardiol 2020; 41: 282-289DOI: 10.1007/s00246-019-02253-6 AbstractEvaluate the efficacy of systemic sirolimus (rapamycin) in preventing in-stent stenosis (ISS) in pediatric intraluminal pulmonary vein stenosis (PVS). Report the adverse events related to sirolimus therapy.

Systemic Sirolimus to Prevent In-Stent Stenosis in Pediatric Pulmonary Vein Stenosis Read More »

Pulmonary Vein Stenosis in Children: A Programmatic Approach Employing Primary and Anatomic Therapy

James A. Kuo, Christopher J. PetitChildren’s Healthcare of Atlanta and Emory University. Columbia University Vagelos College of Physicians and Surgeons and Morgan Stanley Children’s Hospital of New York.United States ChildrenChildren 2021; 8: DOI: 10.3390/children8080663 AbstractPulmonary vein stenosis (PVS) is a difficult condition to treat due to recurrence and progression. In 2017, we developed a comprehensive PVS

Pulmonary Vein Stenosis in Children: A Programmatic Approach Employing Primary and Anatomic Therapy Read More »

Scroll to Top